Raptor Announces NIDDK Provides Additional Data From CyNCh Study Evaluating RP103 in Pediatric NASH at AASLD
November 16, 2015 at 07:12 AM EST
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) today announced researchers have provided additional results from the CyNCh study of RP103 ...